# A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery

> **NCT00636064** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 1671 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Parecoxib Sodium/Valdecoxib
- **DRUG:** Placebo/Valdecoxib
- **OTHER:** Placebo/Placebo

## Key facts

- **NCT ID:** NCT00636064
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** 1671 (ACTUAL)
- **Last updated:** 2008-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00636064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00636064, "A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00636064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*